Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kanthida Kusonmano

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
European Journal of Cancer (Oxford, England : 1990)|October 5, 2014
Loss of progesterone receptor links to high proliferation and increases from primary to metastatic endometrial cancer lesionsIngvild Løberg Tangen, Henrica M J Werner, Anna Berg, et al.
Scientific Reports|June 25, 2026
Gut microbiome diversity across seasons and locations in thai captive Asian elephants (elephas maximus)Nathita Phumthanakorn, Nae Tanpradit, Nlin Arya, et al.
BMC Cancer|May 8, 2012
Lipocalin 2 expression is associated with aggressive features of endometrial cancerMonica Mannelqvist, Ingunn M Stefansson, Elisabeth Wik, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 20, 2012
ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomasHenrica M J Werner, Anna Berg, Elisabeth Wik, et al.
Plos One|May 23, 2014
Switch in FOXA1 status associates with endometrial cancer progressionIngvild Løberg Tangen, Camilla Krakstad, Mari K Halle, et al.
Oncotarget|April 11, 2015
Increased angiogenesis is associated with a 32-gene expression signature and 6p21 amplification in aggressive endometrial cancerIngunn M Stefansson, Maria Raeder, Elisabeth Wik, et al.
Oncotarget|March 25, 2014
Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver geneErling A Hoivik, Kanthida Kusonmano, Mari K Halle, et al.
American Journal of Obstetrics and Gynecology|June 11, 2017
Clinicopathologic and molecular markers in cervical carcinoma: a prospective cohort studyMari Kyllesø Halle, Akinyemi I Ojesina, Hilde Engerud, et al.
Plos One|January 10, 2013
High-throughput mutation profiling of primary and metastatic endometrial cancers identifies KRAS, FGFR2 and PIK3CA to be frequently mutatedCamilla Krakstad, Even Birkeland, Danila Seidel, et al.
Cancers|July 25, 2019
Genetic Aberration Analysis in Thai Colorectal Adenoma and Early-Stage Adenocarcinoma Patients by Whole-Exome SequencingThoranin Intarajak, Wandee Udomchaiprasertkul, Chakrit Bunyoo, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
European Journal of Cancer (Oxford, England : 1990)|October 5, 2014
Loss of progesterone receptor links to high proliferation and increases from primary to metastatic endometrial cancer lesionsIngvild Løberg Tangen, Henrica M J Werner, Anna Berg, et al.
Scientific Reports|June 25, 2026
Gut microbiome diversity across seasons and locations in thai captive Asian elephants (elephas maximus)Nathita Phumthanakorn, Nae Tanpradit, Nlin Arya, et al.
BMC Cancer|May 8, 2012
Lipocalin 2 expression is associated with aggressive features of endometrial cancerMonica Mannelqvist, Ingunn M Stefansson, Elisabeth Wik, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 20, 2012
ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomasHenrica M J Werner, Anna Berg, Elisabeth Wik, et al.
Plos One|May 23, 2014
Switch in FOXA1 status associates with endometrial cancer progressionIngvild Løberg Tangen, Camilla Krakstad, Mari K Halle, et al.
Oncotarget|April 11, 2015
Increased angiogenesis is associated with a 32-gene expression signature and 6p21 amplification in aggressive endometrial cancerIngunn M Stefansson, Maria Raeder, Elisabeth Wik, et al.
Oncotarget|March 25, 2014
Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver geneErling A Hoivik, Kanthida Kusonmano, Mari K Halle, et al.
American Journal of Obstetrics and Gynecology|June 11, 2017
Clinicopathologic and molecular markers in cervical carcinoma: a prospective cohort studyMari Kyllesø Halle, Akinyemi I Ojesina, Hilde Engerud, et al.
Plos One|January 10, 2013
High-throughput mutation profiling of primary and metastatic endometrial cancers identifies KRAS, FGFR2 and PIK3CA to be frequently mutatedCamilla Krakstad, Even Birkeland, Danila Seidel, et al.
Cancers|July 25, 2019
Genetic Aberration Analysis in Thai Colorectal Adenoma and Early-Stage Adenocarcinoma Patients by Whole-Exome SequencingThoranin Intarajak, Wandee Udomchaiprasertkul, Chakrit Bunyoo, et al.
Pageof 4